BACKGROUND Information regarding patient selection for mitral valve repair for chronic kidney disease or end-stage renal disease (ESRD) with severe heart failure (HF) as well as outcome is limited. METHODS AND RESULTS We classified 208 patients with advanced HF symptoms (Stage C/D) undergoing mitral valve repair for functional mitral regurgitation into 3 groups: estimated glomerular filtratio...

End-stage renal disease (ESRD) has significantly increased in developing countries such as Indonesia. Chronic glomerulonephritis is still the leading cause of ESRD, while the numbers of diabetes mellitus patients have significantly risen. Data presented in this article were obtained from various nephrology centers in response to the specific questionnaires distributed by Indonesian Society Neph...

The expanding impact of chronic kidney disease (CKD) due to pandemic diabetes mellitus is recounted emphasizing its epidemiology that has induced global socioeconomic stress on health care systems in industrialized nations now attempting to proffer optimal therapy for end stage renal disease (ESRD). Strategies to delay and perhaps prevent progression of diabetic nephropathy from minimal protein...

Epidemiology of renal replacement therapy: International comparisons of renal replacement therapy. Renal replacement therapy (RRT) remains the most important tool for all patients with end-stage renal disease (ESRD) in the world. Patients are usually listed in the national renal registries which report demographic data, incidence, prevalence and outcome. Differences in acceptance of the RRT, pa...

BACKGROUND The availability of more effective treatments for severe lupus nephritis may have influenced the rate at which end-stage renal disease (ESRD) develops in these patients. OBJECTIVE To examine changes in the incidence of ESRD due to lupus nephritis from 1982 to 1995. METHODS All patients with incident ESRD included in the US Renal Data System from 1982 to 1995 were studied. The US ...

Along with the increase in aging of our population, the proportion of older patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) is on the rise as a result of the accumulation of comorbidities as well as biological processes associated with aging. Older patients with acute kidney injury (AKI) comprise an increasing proportion of patients with CKD/ESRD as well. In this r...

OBJECTIVE To study the effect of renal disease on the standardized mortality ratio (SMR) and life expectancy of patients with systemic lupus erythematosus (SLE). METHODS Patients whose diagnosis met ≥4 American College of Rheumatology criteria for SLE were longitudinally followed up from 1995 to 2011. The cumulative survival rate, SMR, and life expectancy were calculated, and the effect of re...

Diabetic nephropathy is becoming the leading cause of end-stage renal disease (ESRD) worldwide. Although the prognosis of patients with diabetes and ESRD receiving Renal Replacement Therapy (RRT) has improved greatly, the presence of pre-existing cardiovascular disease means that the survival and medical rehabilitation of diabetics continue to be inferior to that of non-diabetics. RRT should be...

Chronic kidney disease (CKD) has been considered an uncommon condition requiring specialist management. The traditional view of CKD has been of patients with end-stage renal disease (ESRD) requiring dialysis or a kidney transplant as forms of renal replacement therapy (RRT). However the prevalence of CKD is much higher than previously appreciated and this has provided a stimulus to the integrat...